Ingevity Corp Stock
Ingevity Corp shows a slight decrease today, losing -€0.500 (-0.780%) compared to yesterday.
Our community is currently high on Ingevity Corp with 5 Buy predictions and 0 Sell predictions.
However, we have a potential of -7.09% for Ingevity Corp as the target price of 59 € is below the current price of 63.5 €.
Pros and Cons of Ingevity Corp in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ingevity Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ingevity Corp | -0.780% | 3.084% | 14.828% | 110.823% | 27.102% | - | - |
| Barito Pacific Tbk PT | 6.670% | 44.262% | 1.734% | 319.048% | -43.590% | 166.667% | 102.299% |
| PTT Global Chemical -fgn- | 1.110% | 0.552% | 31.884% | 112.617% | 70.093% | -24.793% | -44.172% |
| Braskem Pfd ADR | 0.000% | -0.645% | -21.429% | 6.207% | 27.273% | -55.036% | -76.124% |
Comments
Ingevity (NGVT) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for NGVT provided by MarketBeat
Ingevity (NGVT) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Show more
Ratings data for NGVT provided by MarketBeat
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $64.00 to $70.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for NGVT provided by MarketBeat
News
Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 Points
On February 17, 2026, EVR Research disclosed a new position in Ingevity (NYSE:NGVT), acquiring 100,000 shares worth $5.92 million.
In a U.S. Securities and Exchange Commission (SEC) filing dated
